Tag : Commission

Latest News

The European Commission Approves Expanded Use of Janssen’s STELARA® (ustekinumab) for the Treatment of Paediatric Patients With Moderate to Severe Plaque Psoriasis

Newsemia
BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission (EC) has approved the expanded use of STELARA® (ustekinumab)...
Latest News

Russian Investigation Retracts More Than 800 Scientific Papers Due To Issues

Newsemia
In recent news, academic journals in Russia are reportedly retracting more or less 800 papers after a probe by a commission appointed by the Russian...
Latest News

Servier v Commission: following in the footsteps of Lundbeck

Newsemia
Tepper, R; (2019) Servier v Commission: following in the footsteps of Lundbeck. UCL Journal of Law and Jurisprudence , 8 (2) , Article 7. 10.14324/111.2052-1871.122...
Latest News

New metrics for the Lancet Standing Commission on Liver Disease in the UK

Newsemia
Williams, R; Alexander, G; Aspinall, R; Bosanquet, J; Camps-Walsh, G; Cramp, M; Day, N; … Yeoman, A; + view all Williams, R; Alexander, G; Aspinall,...
Latest News

Janssen annonce l’approbation de l’ERLEADA® (apalutamide) par la Commission européenne pour les patients atteints d’un cancer de la prostate résistant à la castration non métastatique et présentant un risque élevé de métastases

Newsemia
BEERSE, Belgique–(BUSINESS WIRE)–Les sociétés pharmaceutiques Janssen de Johnson & Johnson ont annoncé aujourd'hui que la Commission européenne (CE) a accordé une autorisation de mise sur...
Pediatrics

Children's Hospital Celebrates European Commission Approval of First-of-Its-Kind Gene Therapy for Blindness

Newsemia
Children’s Hospital of Philadelphia celebrates a pivotal moment in medicine: approval by the European Commission of LUXTURNA(r) (voretigene neparvovec), the first and only gene therapy...
Latest News

Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) to Treat Patients with Cystic Fibrosis Aged 12 to <24 months with Certain Mutations in the CFTR Gene

Newsemia
LONDON–(BUSINESS WIRE)–Vertex Pharmaceuticals (Europe) Limited today announced that the European Commission has granted approval of the label extension for KALYDECO® (ivacaftor) to include the treatment...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy